Fernwood Investment Management, LLC Bridge Bio Pharma, Inc. Transaction History

Fernwood Investment Management, LLC

$303 Million
Q3 2024

A detailed history of Fernwood Investment Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Fernwood Investment Management, LLC holds 261,735 shares of BBIO stock, worth $8.63 Million. This represents 2.2% of its overall portfolio holdings.

Number of Shares

261,735

Previous 255,535 2.43%

Holding current value

$8.63 Million

Previous $6.47 Million 2.95%

% of portfolio

2.2%

Previous 2.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$23.91 - $31.3 $148,242 - $194,060	6,200 Added 2.43%	261,735 $6.66 Million
Q2 2024 Jul 31, 2024	BUY	$23.0 - $31.04 $239,545 - $323,281	10,415 Added 4.25%	255,535 $6.47 Million
Q1 2024 May 13, 2024	BUY	$27.35 - $40.45 $262,560 - $388,320	9,600 Added 4.08%	245,120 $7.58 Million
Q4 2023 Feb 05, 2024	SELL	$24.02 - $43.89 $2,402 - $4,389	-100 Reduced 0.04%	235,520 $9.51 Million
Q3 2023 Nov 08, 2023	SELL	$16.89 - $35.01 $72,204 - $149,667	-4,275 Reduced 1.78%	235,620 $6.21 Million
Q2 2023 Aug 09, 2023	BUY	$13.29 - $18.01 $38,806 - $52,589	2,920 Added 1.23%	239,895 $4.13 Million
Q1 2023 May 01, 2023	BUY	$7.17 - $18.55 $243,600 - $630,236	33,975 Added 16.74%	236,975 $3.93 Million
Q4 2022 Feb 07, 2023	SELL	$6.74 - $11.52 $10,447 - $17,856	-1,550 Reduced 0.76%	203,000 $1.55 Million
Q3 2022 Nov 09, 2022	BUY	$7.94 - $12.36 $163,961 - $255,234	20,650 Added 11.23%	204,550 $2.03 Million
Q2 2022 Aug 11, 2022	BUY	$5.21 - $12.14 $60,305 - $140,520	11,575 Added 6.72%	183,900 $1.67 Million
Q1 2022 May 03, 2022	BUY	$7.34 - $17.16 $65,509 - $153,153	8,925 Added 5.46%	172,325 $1.75 Million
Q4 2021 Feb 09, 2022	BUY	$11.38 - $53.41 $62,612 - $293,861	5,502 Added 3.48%	163,400 $2.73 Million
Q3 2021 Oct 28, 2021	BUY	$46.87 - $64.24 $198,072 - $271,478	4,226 Added 2.75%	157,898 $7.4 Million
Q2 2021 Aug 05, 2021	BUY	$46.47 - $63.93 $120,217 - $165,386	2,587 Added 1.71%	153,672 $9.37 Million
Q1 2021 May 06, 2021	BUY	$55.47 - $72.35 $13,867 - $18,087	250 Added 0.17%	151,085 $9.31 Million
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $268,660 - $497,770	7,000 Added 4.87%	150,835 $10.7 Million
Q3 2020 Nov 03, 2020	SELL	$27.2 - $42.19 $34,408 - $53,370	-1,265 Reduced 0.87%	143,835 $5.4 Million
Q2 2020 Aug 06, 2020	BUY	$22.22 - $35.69 $929,907 - $1.49 Million	41,850 Added 40.53%	145,100 $4.73 Million
Q1 2020 Apr 30, 2020	SELL	$16.11 - $36.23 $18,526 - $41,664	-1,150 Reduced 1.1%	103,250 $2.99 Million
Q4 2019 Feb 10, 2020	BUY	$17.96 - $46.63 $165,232 - $428,996	9,200 Added 9.66%	104,400 $3.66 Million
Q3 2019 Nov 14, 2019	BUY	$20.13 - $32.38 $1.92 Million - $3.08 Million	95,200 New	95,200 $2.04 Million

Others Institutions Holding BBIO

# of Institutions

294

Shares Held

171M

Call Options Held

10.4M

Put Options Held

2.33M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.89B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fernwood Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fernwood Investment Management, LLC with notifications on news.

Account

Fernwood Investment Management, LLC Bridge Bio Pharma, Inc. Transaction History